Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Indo-Rama Synthetics Tbk. (INDR) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Indo-Rama Synthetics Tbk.Trade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Indo-Rama Synthetics Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Indo-Rama Synthetics Tbk. trades at Rp2,360 (market cap 1.58T, 400 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 164.65B, 43.9K 24h volume). The key difference: Indo-Rama Synthetics Tbk. is far larger — about 9.6× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (43.9K versus 400). Which is the better fit depends on your goals.

INDROBAT
Market Cap
1.58T164.65B
Volume
40043.9K
Lot
4439
Turnover
944K10.6M
Average Price
2,360241.43
Value
944K10.6M
Indicative Equilibrium Price
238
Indicative Equilibrium Volume
100

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

INDR
View details
OBAT
View details

About Indo-Rama Synthetics Tbk.

PT. Indo-Rama Synthetics Tbk (the Company) was established within the framework of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial DeedNo. 21 dated April 3, 1974, of Gustaaf Hoemala Soangkoepon Loemban Tobing, SH, public notary in Jakarta.

Read more on INDR

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT